# Probiotics and Hemodynamic Changes in Cirrhosis

> **NCT05231772** · NA · COMPLETED · sponsor: **I.M. Sechenov First Moscow State Medical University** · enrollment: 40 (actual)

## Conditions studied

- Cirrhosis

## Interventions

- **DRUG:** Saccharomyces Boulardii Probiotic Supplement
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05231772
- **Lead sponsor:** I.M. Sechenov First Moscow State Medical University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-03-01
- **Primary completion:** 2022-03-29
- **Final completion:** 2022-03-29
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2022-03-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05231772

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05231772, "Probiotics and Hemodynamic Changes in Cirrhosis". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05231772. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*